Schedule 13G ownership disclosure
N/A
Security class unavailable · CUSIP: 01345P106
Event date: 2017-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 845,000
- Percent of class
- 9.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001019056-17-000555
- Form type
- SC 13G
- Filer
- ALBIREO PHARMA, INC.
- CIK
- CIK 1322505
- Filed
- Jun 05, 2017
- Reporting period
- May 24, 2017
- Description
- Schedule 13G beneficial ownership